110 related articles for article (PubMed ID: 27393579)
1. Adjuvant Antiangiogenic Treatment for Aggressive Giant Cell Lesions of the Jaw: A 20-Year Experience at Massachusetts General Hospital.
Schreuder WH; Peacock ZS; Ebb D; Chuang SK; Kaban LB
J Oral Maxillofac Surg; 2017 Jan; 75(1):105-118. PubMed ID: 27393579
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant antiangiogenic therapy for giant cell tumors of the jaws.
Kaban LB; Troulis MJ; Wilkinson MS; Ebb D; Dodson TB
J Oral Maxillofac Surg; 2007 Oct; 65(10):2018-24; discussion 2024. PubMed ID: 17884531
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws.
Kaban LB; Troulis MJ; Ebb D; August M; Hornicek FJ; Dodson TB
J Oral Maxillofac Surg; 2002 Oct; 60(10):1103-11; discussion 1111-3. PubMed ID: 12378481
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and surgical therapy for the central giant cell granuloma: A long-term retrospective cohort study.
Schreuder WH; van den Berg H; Westermann AM; Peacock ZS; de Lange J
J Craniomaxillofac Surg; 2017 Feb; 45(2):232-243. PubMed ID: 28087284
[TBL] [Abstract][Full Text] [Related]
5. Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases.
O'Connell JE; Kearns GJ
Ir J Med Sci; 2013 Jun; 182(2):163-70. PubMed ID: 23099991
[TBL] [Abstract][Full Text] [Related]
6. Primary jaw tumors in children.
Abramowicz S; Goldwaser BR; Troulis MJ; Padwa BL; Kaban LB
J Oral Maxillofac Surg; 2013 Jan; 71(1):47-52. PubMed ID: 22766384
[TBL] [Abstract][Full Text] [Related]
7. Maxillofacial and axial/appendicular giant cell lesions: unique tumors or variants of the same disease?--A comparison of phenotypic, clinical, and radiographic characteristics.
Resnick CM; Margolis J; Susarla SM; Schwab JH; Hornicek FJ; Dodson TB; Kaban LB
J Oral Maxillofac Surg; 2010 Jan; 68(1):130-7. PubMed ID: 20006167
[TBL] [Abstract][Full Text] [Related]
8. Aggressive giant cell lesion of the jaws: a review of management options and report of a mandibular lesion treated with denosumab.
O'Connell JE; Bowe C; Murphy C; Toner M; Kearns GJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):e191-8. PubMed ID: 26340897
[TBL] [Abstract][Full Text] [Related]
9. Benign Pediatric Jaw Lesions at Massachusetts General Hospital Over 13 Years.
Chen Y; Zhang J; Han Y; Troulis MJ; August M
J Oral Maxillofac Surg; 2020 Jul; 78(7):1124-1135. PubMed ID: 32114009
[TBL] [Abstract][Full Text] [Related]
10. Aggressive Central Giant Cell Granuloma of the Mandible Treated With Conservative Surgical Enucleation and Interferon-α-2a: Complete Remission With Long-Term Follow-Up.
Tarsitano A; Del Corso G; Pizzigallo A; Marchetti C
J Oral Maxillofac Surg; 2015 Nov; 73(11):2149-54. PubMed ID: 25985764
[TBL] [Abstract][Full Text] [Related]
11. Aggressive central giant cell lesion of the maxilla: surgical management and the use of adjuvant interferon alfa-2a.
Baker SB; Parikh PM; Rhodes DN; Abu-Ghosh A; Shad AT
Plast Reconstr Surg; 2008 Aug; 122(2):77e-79e. PubMed ID: 18626327
[No Abstract] [Full Text] [Related]
12. Do histologic criteria predict biologic behavior of giant cell lesions?
Peacock ZS; Resnick CM; Susarla SM; Faquin WC; Rosenberg AE; Nielsen GP; Schwab JH; Hornicek F; Ebb DH; Dodson TB; Kaban LB
J Oral Maxillofac Surg; 2012 Nov; 70(11):2573-80. PubMed ID: 22365980
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma of the jaws: factors influencing prognosis.
Granowski-LeCornu M; Chuang SK; Kaban LB; August M
J Oral Maxillofac Surg; 2011 Sep; 69(9):2368-75. PubMed ID: 21288615
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation on the surgical treatment of jaw bones ameloblastic lesions. Experience with 20 clinical cases.
D'Agostino A; Fior A; Pacino GA; Bedogni A; Santis D; Nocini PF
Minerva Stomatol; 2001; 50(1-2):1-7. PubMed ID: 11529193
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis.
Dewsnup NC; Susarla SM; Abulikemu M; Faquin WC; Kaban LB; August M
J Oral Maxillofac Surg; 2008 May; 66(5):928-33. PubMed ID: 18423282
[TBL] [Abstract][Full Text] [Related]
16. Myofibromas of the jaws in children.
Abramowicz S; Simon LE; Kozakewich HP; Perez-Atayde AR; Kaban LB; Padwa BL
J Oral Maxillofac Surg; 2012 Aug; 70(8):1880-4. PubMed ID: 22209099
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of NF-ĸB and their inhibitory subunits IĸBα and IĸBβ in giant cell lesions of the jaws: implications for their clinical behavior.
Tobón-Arroyave SI; Hurtado-García P; García-Quintero OD; Isaza-Guzmán DM; Flórez-Moreno GA
J Oral Pathol Med; 2015 Oct; 44(9):752-60. PubMed ID: 25413222
[TBL] [Abstract][Full Text] [Related]
18. Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior?
Peacock ZS; Jordan RC; Schmidt BL
J Oral Maxillofac Surg; 2012 Aug; 70(8):1860-6. PubMed ID: 22104131
[TBL] [Abstract][Full Text] [Related]
19. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
20. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
